Schrezenmeier, E.
99  results:
Search for persons X
?
 
?
2

Sicherheit und Wirksamkeitshinweise zum Off-label-Einsatz v..:

Proft, F. ; Schulze-Koops, H. ; Grunke, M....
Zeitschrift für Rheumatologie.  77 (2017)  1 - p. 28-39 , 2017
 
?
3

Immunologic Long-term Outcomes of Living-Related Kidney Tra..:

Khadzhynov, D. ; Halleck, F. ; Lehner, L....
Transplantation Proceedings.  49 (2017)  10 - p. 2265-2268 , 2017
 
?
4

Incidence of Infectious Disease and Malignancies After Ritu..:

Schrezenmeier, E. ; Budde, K. ; Staeck, O....
Transplantation Proceedings.  49 (2017)  10 - p. 2269-2273 , 2017
 
?
5

Successful Recovery of Acute Renal Transplant Failure in Re..:

Schrezenmeier, E. ; Wu, K. ; Halleck, F....
American Journal of Transplantation.  17 (2017)  3 - p. 819-823 , 2017
 
?
 
?
7

Lupus und Thrombophilie: Antiphospholipidsyndrom:

Lettau, M. ; Schrezenmeier, E. V. ; Specker, C..
Zeitschrift für Rheumatologie.  79 (2020)  4 - p. 332-341 , 2020
 
?
10

Efficient CRISPR/Cas9-mediated mutagenesis in primary human..:

Le, T.A ; Chu, V.T ; Lino, A.C...
http://edoc.mdc-berlin.de/22920/1/22920oa.pdf.  , 2022
 
?
11

BTLA expression is reduced in SLE B cells and controls plas..:

Stefanski, AL ; Wiedemann, A ; Lettau, M...
Sawaf M, Fauny JD, Felten R, Sagez F, Gottenberg JE, Dumortier H, Monneaux F. Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells. JCI Insight. 2018 Jul;3(13):e99711. DOI:10.1172/jci.insight.99711.  , 2021
 
1-15